WINMAPᵀᴹ

 

Category: *CDMO

Exhibitor: WCC BIOMEDICAL CO., LTD.

Booth No: L332

 

Characteristic

 

WINMAP™ is a proprietary microneedle platform self-developed by WCC through years of dedicated research and development. Its core strength lies in enabling the incorporation of various active pharmaceutical ingredients (APIs) into microneedles for a wide range of applications—including cosmetics, healthcare, pharmaceuticals, and vaccines.
The platform is built on four integrated modules that work together as a complete development and manufacturing system. M²DB (Microneedle Material Database) provides a curated library of biocompatible materials and formulation data to accelerate early-stage development. PD²F (Penetration / Dissolving / Diffusion / Function) governs how the microneedle interacts with the skin—ensuring predictable drug release profiles tailored to each application. PLC (Precision Loading & Coating) controls the exact drug load applied to each needle tip, delivering consistent dosing across every patch. AMASS (Automatic Mass Production System) ties it all together at scale, enabling high-throughput manufacturing with minimal human intervention.
As an end-to-end solution, WINMAP™ supports three microneedle formats — coating-type, dissolving-type, and hydrogel-type — giving partners the flexibility to select the most suitable delivery mechanism for their target indication and drug profile. Our current production capacity stands at 10 million patches per year, with a maximum designed capacity exceeding 30 million patches per year. Combined with AI-assisted process monitoring, the platform maintains a consistent yield rate of 95%.
If you're interested in collaborating with us or would like to learn more about our platform and MAP production process, we invite you to visit our booth (L332) and speak with us directly.

 

Other Products

 

• 

  DS MAPs

• 

  Vaccine Microarray Patches

• 

  WINMAP™ Mini

• 

  Power Patch

• 

  V Patch

 

 

 

Back